Todd Trautner, Senior Director of Government Affairs at Natera, shared a post on LinkedIn:
“My colleague at Natera , Dr. Joe Lennerz continues to provide one of the most thoughtful and balanced voices on the future of precision medicine.
His perspective is an important reminder that the next generation of diagnostics won’t be defined solely by technological advances, but by our ability to thoughtfully integrate innovation with rigorous clinical evidence, regulatory clarity, and a relentless focus on improving patient care.
As precision oncology, digital pathology, AI, and laboratory-developed tests continue to evolve, these conversations are more important than ever. We need scientific leaders who can bridge innovation, policy, and clinical implementation—and Joe’s insights do exactly that.
Well worth the read for anyone involved in diagnostics, pathology, laboratory medicine, or healthcare policy. Especially, in light of CMS proposed RFI on CLIA modernization.
Thank you, Joe, for continuing to elevate this important discussion.”